2nd CDDF Multi-stakeholder Workshop on The Use of Real-World Data to Optimize Oncology Drug Development and Access
November 21, 2019 - November 22, 2019
Amsterdam, Netherlands
Due to the current interest in Real World Data both from Industry but especially the EMA and FDA, the Cancer Drug Development Forum organizes the 2nd CDDF multi-stakeholder workshop on the Use of Real-World Data to Optimize Oncology Drug Development and Access on 21-22 November 2019 in Amsterdam, Netherlands.
The aim of the workshop is to have a multi-stakeholder discussion representing regulators, clinicians, HTA / payers, and policy makers on the challenges of developing RWD proposals in Oncology and share current experience on the best sources of RWD of high quality in Oncology Drug Development. We will discuss ways to enhance knowledge on benefit/risk as well as development and access to optimal treatment regimens.
The second edition will focus particularly on issues concerning methodology of collecting good quality and relevant information, and the specific requirement of Regulators to maximise the use of RWD in licensing decisions. We will also explore possible solutions to the current challenges and implement multi-stakeholder approach in search of agreements.
More information on the workshop website.
Next events
EORTC Head and Neck Cancer Group Spring Meeting
April 26 - April 27
Hamburg, DE
ESTRO 2024
May 3 - May 7
Glasgow
EORTC Lung Cancer Group Spring Meeting
May 16 - May 18
Malaga, Spain
EORTC Gynecological Cancer Group Spring Meeting
May 16 - May 17
Barcelona, Spain
EORTC Genito-Urinary Cancer Group Spring Meeting
May 17
Barcelona, Spain